Catalog name Description price
R-R-2819 Beinaglutide CAS No.123475-27-4 Beinaglutide/CAS No.123475-27-4 is a human GLP-1 polypeptide that shares almost 100% homology with human GLP-1 (7–36). Beinaglutide displays does-dependent effects in glycemic control, inhibiting food intake and gastric empty and promoting weight loss. Beinaglutide has the potential for the research of overweight/obesity and nonalcoholic steatohepatitis (NASH). price>
R-R-2820 GLP-2(1-33)(human) CAS No.223460-79-5 GLP-2(1-33) (human)/CAS No.223460-79-5 is an enteroendocrine hormone which can bind to the GLP-2 receptor and stimulate the growth of intestinal epithelium. price>
R-R-2821 Lotiglipron CAS No.2401892-75-7 Lotiglipron (PF-07081532)/CAS No.2401892-75-7 is an orally active GLP-1R agonist. Lotiglipron reduces glucose and body weight, and can be used for research of Type 2 diabetes mellitus (T2DM). price>
R-R-2822 Exendin-4 acetate CAS No.914454-01-6 Exendin-4 acetate (Exenatide acetate)/CAS No.914454-01-6, a 39 amino acid peptide, is a long-acting glucagon-like peptide-1 receptor agonist with an IC50 of 3.22 nM. price>
R-R-2823 Retatrutide TFA Retatrutide (LY3437943) TFA is a triple agonist peptide of the glucagon receptor (GCGR), glucosedependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R). Retatrutide TFA binds human GCGR, GIPR, and GLP-1R with EC50 values of 5.79, 0.0643 and 0.775 nM, respectively. Retatrutide TFA can be used for the research of obesity. price>
R-R-2824 LGD-6972 CAS No.1207989-09-0 LGD-6972/CAS No.1207989-09-0 is a selective and orally active glucagon receptor antagonist. LGD-6972 has the potential for type 2 diabetes research. price>
R-R-2825 NNC-0640 CAS No.307986-98-7 NNC-0640/CAS No.307986-98-7 is a potent human G-protein-coupled glucagon receptor (GCGR) negative allosteric modulator (NAM) with an IC50 of 69.2 nM. price>
R-R-2826 Lixisenatide acetate CAS No.1997361-87-1 Lixisenatide acetate/CAS No.1997361-87-1 is a glucagon-like peptide-1 (GLP-1) receptor agonist that can be used in the treatment of type 2 diabetes mellitus (T2DM). price>
R-R-2827 GLP-1 moiety from Dulaglutide CAS No.1197810-60-8 GLP-1 moiety from Dulaglutide/CAS No.1197810-60-8 is a 31-amino acid fragment of Dulaglutide which is a glucagon-like peptide 1 receptor (GLP-1) agonist, extracted from patent US 20160369010 A1. price>
R-R-2828 GLP-1R agonist 2 CAS No.281209-71-0 GLP-1R agonist 2 (compound 2)/CAS No.281209-71-0 is a potent GLP-1R agonist. GLP-1R agonist 2 has the potential for the research of metabolic diseases like Type2 Diabetes and Obesity. price>